However, a reduction in the antioxidant activity of SOD1 is not the only pathogenic pathway involved in ALS, since at least 7 ALS-associated SOD1 mutations have preserved enzymatic activity [5,15]. This evidence concerns the gene SOD1 and amyotrophic lateral sclerosis.